A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses
一种新型氨基四氢萘型血清素 (5-HT) 2C 受体特异性激动剂和 5-HT2A 竞争性拮抗剂/5-HT2B 反向激动剂,对精神病具有临床前疗效
期刊:Journal of Pharmacology and Experimental Therapeutics
影响因子:3.1
doi:10.1124/jpet.113.212373
Clinton E Canal, Drake Morgan, Daniel Felsing, Krishnakanth Kondabolu, Neil E Rowland, Kimberly L Robertson, Rajeev Sakhuja, Raymond G Booth